NeuroFine
Miramar, US · Founded 2020 · Delaware corporation
Founders & leadership
BN
Bernie NavarroExecutive
AW
Ajay WakhlooNamed on SEC filing
Board
ML
Marc LitzenbergBoard director
JM
John McEleneyBoard director
DS
Daniel SablyakBoard director
Reported raises · per SEC filings
Form D private placements$4.4M disclosed across 5 rounds · 2021–2026
▶$1MraisedApr 2026 · 14 investors · Other Health CareRule 506(b)
▶$1MraisedApr 2026 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ajay WakhlooExecutive Officer, Director
- John McEleneyDirector
- Daniel SablyakDirector
- Bernie NavarroExecutive Officer
- Marc LitzenbergDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$125KraisedSep 2025 · 2 investors · Other Health CareRule 506(b)
▶$125KraisedSep 2025 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel SablyakDirector
- John McEleneyDirector
- Ajay WakhlooExecutive Officer, Director
- Bernie NavarroExecutive Officer
- Marc LitzenbergDirector
- Offering amount
- $5M
- Amount sold
- $125K
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$886KraisedMar 2025 · 12 investors · Other Health CareRule 506(b)
▶$886KraisedMar 2025 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ajay WakhlooExecutive Officer, Director
- Marc LitzenbergDirector
- John McEleneyDirector
- Bernie NavarroExecutive Officer
- Daniel SablyakDirector
- Offering amount
- $2M
- Amount sold
- $886K
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$709.7KraisedSep 2023 · 16 investors · Other Health CareRule 506(b)
▶$709.7KraisedSep 2023 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ajay WakhlooDirector
- Daniel SablyakDirector
- Marc LitzenbergExecutive Officer, Director
- Bernie NavarroExecutive Officer
- John McEleneyDirector
- Offering amount
- $4M
- Amount sold
- $709.7K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.6MraisedOct 2021 · 38 investors · Other Health CareRule 506(b)
▶$1.6MraisedOct 2021 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bernie NavarroExecutive Officer
- Ajay WakhlooDirector
- Marc LitzenbergExecutive Officer, Director
- Daniel SablyakDirector
- John McEleneyDirector
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has NeuroFine raised?
- NeuroFine has disclosed $4.4M raised across 5 rounds.
- Where is NeuroFine headquartered?
- NeuroFine is headquartered in Miramar, US.